Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Mike Webb, Ph.D.
Founder and CEO at Mike Webb Pharma
Speaker

Profile

Mike Webb PhD was the VP of Development Chemistry and Analysis for GSK in the UK and was heavily involved in developing GSK’s oligonucleotide pipeline. Since leaving GSK in 2016 he has been consulting with Big Pharma and Biotechnology companies in the development, analysis and manufacture of therapeutic oligonucleotides from pre-clinical to marketing submission.

Agenda Sessions

  • Workshop Leaders' Welcome and Opening Remarks

    , 9:00am
    View Session

  • Introduction to Therapeutic Oligonucleotides As a New Drug Class

    , 9:05am
    View Session

  • Therapeutic Oligonucleotide Design

    , 9:30am
    View Session

  • Oligonucleotide Manufacture and Control

    , 12:00pm
    View Session

  • Workshop Leader's Welcome and Opening Remarks

    , 1:30pm
    View Session

  • Workshop PM2: Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides

    , 3:30pm
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Mike at TIDES USA: Oligonucleotide & Peptide Therapeutics